Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prospective randomized trial of Rowachol in patients with obstructive jaundice
KCT0000265Phase 4Recruiting
- Sponsor
- Pharmbio Korea Inc.
- Start
- Apr 2011
- Modality
- Small Molecules, Implantable Devices → Device-based Delivery → Drug Delivery Systems, Transdermal Patches → Device-based Delivery → Drug Delivery Systems
- Countries
- 1
01
Overview
A Phase 4 trial of Rowachol in obstructive jaundice, biliary neoplasm, pancreatic cancer (PC), sponsored by Pharmbio Korea Inc.. Started Apr 2011; status: recruiting.
02
Drugs
Rowachol
03
Conditions
obstructive jaundicebiliary neoplasmpancreatic cancer (PC)
Beyond the preview
Go deeper on KCT0000265.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0000265.